Latest by Gareth Hardy
Diabetes mellitus occurs at an increased frequency in people with HIV infection and may develop at earlier stages than it does in the general population.
A new report suggests that heavy use of poppers might be associated with increased risk of individual virus-associated cancers. This link was observed in HIV-negative men but not in men who were HIV positive.
A huge variety of biological factors, some known and some not known, influence and determine a person's ability to control HIV.
A recent study prospectively followed a high-risk cohort of HIV-positive men who have sex with men to investigate demographic, behavioral, clinical and immunogenic determinants of superinfection.
Good adherence during the first four months of ART makes long-term undetectable viral load more than three times more likely, according to results from a French cohort study.
Research shows the boosted integrase inhibitor-based fixed-dose combination Stribild can be safely crushed without affecting pharmacokinetics.
Starting ART may improve antibody responses that in turn reveal exposure to serotypes of human papillomavirus that are a high risk for anal cancer.
Daily rosuvastatin stabilized clinical markers of chronic COPD progression and might reverse an important marker of pulmonary dysfunction commonly seen in HIV-positive people.
Cytomegalovirus (CMV) may be a driver of harmful immune activation in HIV-positive people, even after more than one year of successful antiretroviral therapy, according to a recent study.
Some interesting immunological results suggest that macrophages in the lungs of HIV-positive people may be impaired, even after viral suppression on ART.